Aurina Receives FDA Fast Track Designation for Voclosporin for the Treatment of Lupus Nephritis Mar 2, 2016
Aurinia Announces Preliminary Topline Data From its Open Label Aurion Study in Lupus Nephritis Feb 8, 2016
Aurinia Pharmaceuticals to Present at the Canaccord Genuity Rare Disease and Bio-Pharma One on One Day Jan 29, 2016
Aurinia Announces Completion of Patient Enrollment in Its Phase 2B AURA-LV Study in Lupus Nephritis Jan 19, 2016
Aurinia Pharmaceuticals Announces Outcome from Data and Safety Monitoring Board for Its Phase 2b Study in Lupus Nephritis – Study to Continue as Planned Nov 24, 2015
